Unitika Ltd
F:UTN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Unitika Ltd
F:UTN
|
JP |
|
T
|
Takara Bio Inc
F:TF2
|
JP |
|
S
|
Sumitomo Pharma Co Ltd
F:DPM
|
JP |
|
L
|
Legal & General Group PLC
F:LGI
|
UK |
|
F3 Uranium Corp
F:GL7
|
CA |
|
S
|
Smiths Group PLC
F:QS2A
|
UK |
|
PPC Ltd
OTC:PPCLY
|
ZA |
|
S
|
Smiths Group PLC
XMUN:QS2A
|
UK |
|
ABC Arbitrage SA
PAR:ABCA
|
FR |
|
C
|
CVS Group PLC
F:4C9
|
UK |
|
K
|
Koppers Holdings Inc
F:KO9
|
US |
|
C
|
Cadeler A/S
F:CA2
|
DK |
|
Lintec Corp
F:57T
|
JP |
|
H
|
Heroux Devtek Inc
F:5D6
|
CA |
|
Kinsale Capital Group Inc
F:KCH
|
US |
|
S
|
Sumitomo Pharma Co Ltd
DUS:DPM
|
JP |
|
M
|
Mitra Adiperkasa Tbk PT
OTC:PMDKF
|
ID |
|
Cikarang Listrindo Tbk PT
F:B2O
|
ID |
|
S
|
Sicily By Car SpA
MIL:SBC
|
IT |
Wall St Price Targets
UTN Price Targets Summary
Unitika Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTN's stock price target?
Not Available
UTN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Unitika Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 8%.
What is the Gross Profit forecast for Unitika Ltd?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 2 years is -2%.